181 related articles for article (PubMed ID: 29339175)
41. Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis.
Weissferdt A; Moran CA
Am J Surg Pathol; 2011 Sep; 35(9):1305-10. PubMed ID: 21836478
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
Nakagawa K; Matsuno Y; Kunitoh H; Maeshima A; Asamura H; Tsuchiya R
Chest; 2005 Jul; 128(1):140-4. PubMed ID: 16002927
[TBL] [Abstract][Full Text] [Related]
43. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
Hayashi A; Fumon T; Miki Y; Sato H; Yoshino T; Takahashi K
J Clin Exp Hematop; 2013; 53(1):9-19. PubMed ID: 23801129
[TBL] [Abstract][Full Text] [Related]
44. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour.
Chang KC; Wu MH; Jones D; Chen FF; Tseng YL
J Pathol; 2006 Oct; 210(2):224-33. PubMed ID: 16917804
[TBL] [Abstract][Full Text] [Related]
45. Poorly Differentiated Nonkeratinizing Squamous Cell Carcinoma of the Thymus: Clinicopathologic and Molecular Genetic Study of 25 Cases.
Suster D; Pihan G; Mackinnon AC; Suster S
Am J Surg Pathol; 2018 Sep; 42(9):1224-1236. PubMed ID: 29975245
[TBL] [Abstract][Full Text] [Related]
46. [Clinicopathologic characteristics of head and neck carcinoma showing thymus-like element].
Cui XJ; Zhang CY; Su P; Lyu B; Ren YB; Fan XS; Zhang XF; Wang Y; Song YH; Liu ZY
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):155-159. PubMed ID: 28297754
[No Abstract] [Full Text] [Related]
47. Primary thymic carcinoma: a clinicopathological and immunohistochemical study.
Shimizu J; Hayashi Y; Morita K; Arano Y; Yoshida M; Oda M; Murakami S; Watanabe Y; Nonomura A
J Surg Oncol; 1994 Jul; 56(3):159-64. PubMed ID: 7518018
[TBL] [Abstract][Full Text] [Related]
48. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.
Dorfman DM; Shahsafaei A; Chan JK
Am J Surg Pathol; 1997 Aug; 21(8):936-40. PubMed ID: 9255257
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical detection of p63 and XIAP in thymic hyperplasia and thymomas.
Wu M; Sun K; Gil J; Gan L; Burstein DE
Am J Clin Pathol; 2009 May; 131(5):689-93. PubMed ID: 19369629
[TBL] [Abstract][Full Text] [Related]
50. [Eight cases of thymic carcinoma].
Ito H; Obara T; Sasano S; Onuki T; Nitta S
Nihon Kyobu Geka Gakkai Zasshi; 1994 Nov; 42(11):2060-7. PubMed ID: 7836817
[TBL] [Abstract][Full Text] [Related]
51. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
Walts AE; Hiroshima K; Marchevsky AM
Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
[TBL] [Abstract][Full Text] [Related]
52. Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor.
Fetsch JF; Laskin WB; Michal M; Remotti F; Heffner D; Ellis G; Furlong M; Miettinen M
Am J Surg Pathol; 2004 Oct; 28(10):1360-70. PubMed ID: 15371953
[TBL] [Abstract][Full Text] [Related]
53. Thymic basaloid carcinoma: a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma.
Brown JG; Familiari U; Papotti M; Rosai J
Am J Surg Pathol; 2009 Aug; 33(8):1113-24. PubMed ID: 19461509
[TBL] [Abstract][Full Text] [Related]
54. Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases.
Kriegsmann M; Muley T; Harms A; Tavernar L; Goldmann T; Dienemann H; Herpel E; Warth A
Diagn Pathol; 2015 Dec; 10():210. PubMed ID: 26643918
[TBL] [Abstract][Full Text] [Related]
55. Intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation; comparison with thymic lymphoepithelioma-like carcinoma and a possibility of development from a multipotential stem cell.
Hirokawa M; Miyauchi A; Minato H; Yokoyama S; Kuma S; Kojima M
APMIS; 2013 Jun; 121(6):523-30. PubMed ID: 23176314
[TBL] [Abstract][Full Text] [Related]
56. Myoid cells in the human thymus and thymoma revealed by three different immunohistochemical markers for striated muscle.
Sato T; Tamaoki N
Acta Pathol Jpn; 1989 Aug; 39(8):509-19. PubMed ID: 2816366
[TBL] [Abstract][Full Text] [Related]
57. Anaplastic thymic carcinoma: a clinicopathologic and immunohistochemical study of 6 cases.
Weissferdt A; Moran CA
Hum Pathol; 2012 Jun; 43(6):874-7. PubMed ID: 22055398
[TBL] [Abstract][Full Text] [Related]
58. Thymoma with prominent cystic and hemorrhagic changes and areas of necrosis and infarction: a clinicopathologic study of 25 cases.
Moran CA; Suster S
Am J Surg Pathol; 2001 Aug; 25(8):1086-90. PubMed ID: 11474295
[TBL] [Abstract][Full Text] [Related]
59. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
60. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.
Tateyama H; Eimoto T; Tada T; Hattori H; Murase T; Takino H
Am J Clin Pathol; 1999 Feb; 111(2):235-40. PubMed ID: 9930146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
